These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Analysis of the domain structure of elongation factor-2 kinase by mutagenesis. Diggle TA; Seehra CK; Hase S; Redpath NT FEBS Lett; 1999 Aug; 457(2):189-92. PubMed ID: 10471776 [TBL] [Abstract][Full Text] [Related]
10. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase. Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818 [TBL] [Abstract][Full Text] [Related]
11. Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus. Arora S; Yang JM; Craft J; Hait W Biochem Biophys Res Commun; 2002 May; 293(3):1073-6. PubMed ID: 12051769 [TBL] [Abstract][Full Text] [Related]
12. Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence. Tavares CD; O'Brien JP; Abramczyk O; Devkota AK; Shores KS; Ferguson SB; Kaoud TS; Warthaka M; Marshall KD; Keller KM; Zhang Y; Brodbelt JS; Ozpolat B; Dalby KN Biochemistry; 2012 Mar; 51(11):2232-45. PubMed ID: 22329831 [TBL] [Abstract][Full Text] [Related]
13. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor. Piserchio A; Isiorho EA; Dalby KN; Ghose R J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726 [TBL] [Abstract][Full Text] [Related]
14. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION. Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550 [TBL] [Abstract][Full Text] [Related]
15. Determinants for substrate phosphorylation by Dictyostelium myosin II heavy chain kinases A and B and eukaryotic elongation factor-2 kinase. Crawley SW; Côté GP Biochim Biophys Acta; 2008 Jun; 1784(6):908-15. PubMed ID: 18381083 [TBL] [Abstract][Full Text] [Related]
16. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review. Li S; Li Y; Bai Y Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250 [TBL] [Abstract][Full Text] [Related]
17. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact. Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903 [TBL] [Abstract][Full Text] [Related]
18. Transient up-regulation of elongation factor-2 kinase (Ca2+/calmodulin-dependent protein kinase III) messenger RNA in developing mouse brain. Sakagami H; Nishimura H; Saito R; Kondo H Neurosci Lett; 2002 Sep; 330(1):41-4. PubMed ID: 12213630 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of elongation factor 2: a key mechanism regulating gene expression in vertebrates. Ryazanov AG; Spirin AS New Biol; 1990 Oct; 2(10):843-50. PubMed ID: 1964087 [TBL] [Abstract][Full Text] [Related]
20. Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin. Lee K; Alphonse S; Piserchio A; Tavares CD; Giles DH; Wellmann RM; Dalby KN; Ghose R Structure; 2016 Sep; 24(9):1441-51. PubMed ID: 27499441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]